Johns Hopkins University ACTG Community Advisory Board

Eligible participants are: a) aged 18 years or older, b) cisgender or transgender woman, c) Black or African American racial/ethnic identity, and d) able to read, speak, and understand English. I'm seeking to enroll 350 Black women of all ages with and without HIV throughout the US. Participants receive $40 compensation and can complete the screener using the following link:https://redcap.link/qqxb3eyx.

Happy Holidays from the BEST Johns Hopkins University ACTG Community Advisory Board ❣️

Paul Edmonds: California's 'City of Hope' patient becomes fifth in the world to be cured of HIV 'I still have to remind myself that it's real. But I'm feeling it,' Paul Edmonds said of his miraculous recovery

How COVID-19 Compromised Gains in Controlling HIV The pandemic slowed improvements in viral suppression and worsened health disparities, hampering efforts to reach HIV elimination goals.

New Orleans Marks a Year of Bouncing to End HIV NOLA’s “Bounce to Zero” campaign celebrates accomplishments and recommits to fighting HIV.

Mpox surge in Congo raises concerns world will ignore warnings again Authorities confirm the first sexual spread of mpox in Congo during a surge that has led to more deaths than last year’s global outbreak.

Global fight against HIV is at risk Will the United States remain committed to a landmark health program it started 20 years ago that saved more than 25 million lives around the world? For a younger generation of physicians, nurses, and researchers today, the depth of despair wrought by the HIV/AIDS epidemic at that time is almost uni...

Women with HIV have three times the risk of cervical cancer, large South African study shows A South African study of more than 500,000 women has shown that women with HIV have approximately three times higher incidence of cervical cancer than women without HIV despite very high antiretroviral coverage. As reported in the International Journal of Cancer, women with HIV developed cervical ca...

In Move to Slash CDC Budget, House Republicans Target Major HIV Program Proposal would cut $1.6 billion from the CDC, decimating Trump's Ending the HIV Epidemic initiative.

People With HIV Remain at Greater Risk for Death Due to COVID-19 COVID mortality declined overall during the omicron wave but less so for people with HIV.

Henrietta Lacks’ family reaches historic settlement for her stolen cells The success of the legal strategy increases the likelihood that this becomes the first in a series of complaints seeking compensation for, and control of, Lacks’ cells.

Researchers Find an Antibody that Targets Omicron and Other SARS-CoV-2 Variants A team led by researchers at Weill Cornell Medicine, the University of Wisconsin-Madison; Scripps Research and the University of Chicago has identified an antibody that appears to block infection by all dominant variants of the virus that causes COVID-19, including omicron, the most recent.

More Studies Explore Weight Gain Linked to HIV Treatment Disruption of fat metabolism and altered gut microbiome may help explain weight changes associated with antiretroviral therapy.

News: The first woman to experience HIV remission remains free of detectable virus 30 months after stopping antiretroviral therapy ( ). In this National Institutes of Health (NIH)-funded study, a woman of mixed-race ancestry with HIV and acute myeloid leukemia received a stem cell transplant that included banked umbilical cord blood with HIV-resistant stem cells. She was able to stop taking ART 37 months post-transplant. Using stem cells from cord blood rather than from compatible adult donors increases the potential to eradicate HIV reservoirs in people of all racial backgrounds who require transplants for other medical conditions. This study was conducted by the International Maternal Pediatric Adolescent AIDS Clinical Trials Network in collaboration with Center for International Blood & Marrow Transplant Research (CIBMTR), StemCyte - A Global Regenerative Therapeutics Company, and the -funded AIDS Clinical Trials Group. Full study results are published in Cell Press: https://www.cell.com/cell/fulltext/S0092-8674(23)00173-3

Vital Signs: Progress Toward Eliminating HIV as a Global Public .. This report describes the worldwide progress of eliminating HIV ..

Please check out our AIDS CLINICAL TRIALS GROUG February Newsletter….I wrote a little blog☺️

ACTG February Newsletter The ACTG is excited to announce that it will make 29 presentations at this year’s Conference on Retroviruses and Opportunistic Infections (CROI), the premier global HIV research conference. ACTG members will attend and present on topics including COVID-19; HIV cure, pathogenesis, treatment and lon...

Weill Cornell Medicine Receives NIH Grant to Improve HIV-Related Cancer Care Abroad Weill Cornell Medicine, Moffitt Cancer Center in Tampa, Fla., and the University of North Carolina School of Medicine have received a $3.5 million, five-year grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to improve screening and preventative treatment of....

New Clinical Trials at Leading HIV Center Paused Over Funding Probe “I worry for my patients,” says a researcher at the Chicago CORE center. The pause also affects trials for cancer, COVID and mpox.

Happy holidays from the Johns Hopkins University’s ACTG Community Advisory Board ❣️🎄🎅

Many Older People With HIV Report Suboptimal Health North American survey finds 76% have impaired physical, mental, sexual or overall health.

How the world can end Covid-19 as a public health threat If there is one key message in the recommendations published in Nature, it is that building global consensus may be the most important step of all, not just to end Covid-19 but to address future challenges.

$8M Awarded to 17 Community Groups Boosting HIV Prevention for Black Women The ViiV Healthcare grants are a key element of the company’s Risk to Reason HIV initiative guided by and for Black women.